Carcinoma, Ehrlich Tumor
Peritoneovenous Shunt
Peritonitis, Tuberculous
Liver Cirrhosis
Ovarian Neoplasms
Sarcoma, Yoshida
Hypertension, Portal
Myxedema
Hepatorenal Syndrome
Neoplasms, Experimental
Pleural Effusion
Peritonitis
Identification and characterization of a homozygous deletion found in ovarian ascites by representational difference analysis. (1/991)
We have performed representational difference analysis (RDA) on DNA from tumor cells and normal fibroblasts isolated from the ascites of a patient with ovarian cancer. Five of six products of the RDA were homozygously deleted from the tumor DNA. One of these products has been characterized and identifies a homozygous deletion of approximately 6.9 Mb at chromosome 9p21 in the original ovarian tumor material. This deletion encompasses CDKN2A (p16), CDKN2B (p15), and IFN-alpha. PCR analysis of other tumor cell lines using the novel STS based on the RDA product has shown it to lie between IFN-alpha and p16, and to identify the distal extent of a homozygous deletion in another ovarian cancer cell line. These data provide further evidence for a tumor suppressor locus distinct from, but mapping close to, p16 on 9p21. Cytogenetic analysis using comparative genomic hybridization (CGH) performed on the same primary tumor confirmed a loss of material from chromosome 9p. However, the CGH technique had neither the resolution nor the sensitivity to define a subregion of homozygous loss. (+info)Antibiotic penetrance of ascitic fluid in dogs. (2/991)
Antibiotic concentrations in ascitic fluid after parenteral therapy may be important in the treatment of peritonitis. We have created ascites in dogs by partial ligation of the inferior vena cava. Ascitic fluid volume was measured at the time each antibiotic was administered. Nine antibiotics were studied in the same three dogs. Antibiotic concentration in ascitic fluid was found to vary inversely with ascites volume. Percentage of penetration (ratio of ascites peak to serum peak x100) ranged from 5.8 to 65% among the drugs studied. Only metronidazole showed a statistically significant higher percentage of penetration than other antimicrobials. Concentrations in ascitic fluid after single doses of cephalothin (15 mg/kg) and the aminoglycosides (2 mg/kg, gentamicin and tobramycin; 7.5 mg/kg, amikacin and kanamycin) did not exceed the minimum inhibitory concentration of many gram-negative rods and may justify the use of higher than usual initial parenteral doses, or possibly initial intraperitoneal administration in seriously ill patients. (+info)An endonuclease from mouse cells specific for single-stranded DNA. (3/991)
An endonuclease with a molecular weight of about 70000 (5-6S) was extensively purified from mouse ascites cells. The enzyme specifically attacks single-stranded DNA which is degraded mainly to oligonucleotides, with 5-10 residues. Supercoiled covalently closed circular phage DNA is converted to the linear relaxed form. The enzyme activity is highly sensitive to salt and can be stimulated by reagents lowering the dielectric constant of the buffer such as dimethylsulfoxide and glycerol. (+info)Hyperreactio luteinalis associated with chronic renal failure. (4/991)
Hyperreactio luteinalis is a rare benign condition characterized by bilateral ovarian enlargement associated with pregnancies where high concentrations of maternal serum human chorionic gonadotrophins are present. This condition may mimic the ovarian hyperstimulation syndrome. We report a case of a 34 year old woman with a history of chronic renal failure on haemodialysis who presented at 10 weeks' gestational age with hyperreactio luteinalis which was treated conservatively. Because of chronic renal failure, the presentation and course of the disease was different from that which has been previously reported. (+info)Lymph and pulmonary response to isobaric reduction in plasma oncotic pressure in baboons. (5/991)
Plasma colloid osmotic pressure was reduced by 76% (from 19.6 +/- 0.6 to 4.7 +/- 1.5 mm Hg) in five baboons while pulmonary capillary hydrostatic pressure was maintained at a normal level. This resulted in fluid retention, weight gain, peripheral edema and ascites, but no pulmonary edema. Thoracic duct lymph flow increased 6-fold and pulmonary lymph flow 7-fold. Thoracic duct lymph had a lower colloid osmotic pressure (2.0 +/- 0.7 mm Hg) than plasma (4.7 +/- 1.5 mm Hg), whereas the colloid osmotic pressure of pulmonary lymph (4.7 +/- 0.7 mm Hg) was the same as that of plasma. The lymph-plasma ratio for albumin fell in thoracic duct lymph but remained unchanged in pulmonary lymph. The difference between plasma colloid osmotic pressure and pulmonary artery wedge pressure decreased from 15.3 +/- 1.9 to -0.7 +/- 2.9 mm Hg. Despite this increase in filtration force, the lungs were protected from edema formation by a decrease of 11 mm Hg in pulmonary interstitial colloid osmotic pressure and a 7-fold increase in lymph flow. (+info)Fas gene mutation in the progression of adult T cell leukemia. (6/991)
Fas antigen (Apo-1/CD95) is an apoptosis-signaling cell surface receptor belonging to the tumor necrosis factor receptor superfamily. Adult T cell leukemia (ATL) cells express Fas antigen and show apoptosis after treatment with an anti-Fas monoclonal antibody. We established the ATL cell line KOB, which showed resistance to Fas-mediated apoptosis, and found that KOB expressed two forms of Fas mRNA, the normal form and a truncated form. The truncated transcript lacked 20 base pairs at exon 9, resulting in a frame shift and the generation of a premature stop codon at amino acid 239. The same mutation was detected in primary ascitic cells and peripheral blood cells. The mutation was not detected in lymph node cells, however, although all of the primary ATL cells were of the same clonal origin. A retroviral-mediated gene transfer of the truncated Fas to Jurkat cells rendered the cells resistant to Fas-mediated apoptosis, suggesting a dominant negative interference mechanism. These results indicate that an ATL subclone acquires a Fas mutation in the lymph nodes, enabling the subclone to escape from apoptosis mediated by the Fas/Fas ligand system and proliferate in the body. Mutation of the Fas gene may be one of the mechanisms underlying the progression of ATL. (+info)Effects of ursodeoxycholic acid on systemic, renal and forearm haemodynamics and sodium homoeostasis in cirrhotic patients with refractory ascites. (7/991)
Systemic arterial vasodilatation has been implicated in the pathogenesis of sodium retention in cirrhosis. Hydrophobic bile acids, which have vasodilatory actions, may be involved. Ursodeoxycholic acid, a hydrophilic bile acid, could potentially decrease systemic arterial vasodilatation, possibly due to its antioxidant effects, and improve sodium handling in cirrhosis. The effects of ursodeoxycholic acid on systemic, renal and forearm haemodynamics, liver function and renal sodium handling were assessed in vasodilated cirrhotic patients with refractory ascites treated with a transjugular intrahepatic porto-systemic shunt (TIPS). Eight cirrhotic patients with refractory ascites without TIPS placement served as controls for the sodium handling effects of ursodeoxycholic acid. From 1 month post TIPS, seven patients were studied before, after 1 month of treatment with ursodeoxycholic acid (15 mg.day-1.kg-1) and at 1 month follow-up. Lipid peroxidation products were used as indices of its antioxidant effects. Ursodeoxycholic acid caused a significant reduction in sodium excretion in both groups (P<0.05). This, in the post-TIPS patients (urinary sodium excretion: 35+/-8 mmol/day at 1 month versus 93+/-21 mmol/day at baseline, P<0.05), was due to a significant increase in sodium reabsorption proximal to the distal tubule (P<0.05), without any significant changes in systemic, renal or forearm haemodynamics, or in liver function. No significant change in lipid peroxidation products was observed. We conclude that: (i) in cirrhotic patients with refractory ascites, ursodeoxycholic acid causes sodium retention, (ii) the abnormality in sodium handling in the post-TIPS cirrhotic patients appears to be the result of a direct effect on the proximal nephron, suggesting that factors other than systemic vasodilatation also contribute to sodium retention in cirrhosis, (iii) caution should be exercised in administering ursodeoxycholic acid in cirrhotic patients with ascites. (+info)Expression of phosphatidylethanolamine N-methyltransferase in Yoshida ascites hepatoma cells and the livers of host rats. (8/991)
Previous studies have implicated phosphatidylethanolamine N-methyltransferase-2 (PEMT2) in the regulation of non-neoplastic liver growth [Tessitore,L., Cui,Z. and Vance,E. (1997) Biochem. J., 322, 151-154]. We have now investigated whether or not PEMT2 is also involved in the control of proliferation of hepatoma cells growing in an animal and cell death by apoptosis in the liver of tumor-bearing rats. PEMT activity was barely detectable and PEMT2 protein was absent in hepatoma cells growing exponentially in vivo whereas CTP:phosphocholine cytidylyltransferase (CT) activity and expression were high. The lack of PEMT2 corresponded with the absence of its mRNA. Both PEMT2 protein and mRNA appeared when cells entered the stationary phase of tumor growth and, in parallel, CT expression decreased. The host liver first became hyperplastic and exhibited a slight increase in CT activity and decrease in PEMT2 expression. During the stationary phase of hepatoma growth the host liver regressed and eventually became hypoplastic following induction of apoptosis. The appearance of apoptosis in the host liver was associated with a marked reduction in both CT activity and expression as well as an enhancement of PEMT activity and PEMT2 expression. McArdle RH7777 hepatoma cells underwent apoptosis when transfected with cDNA for PEMT2. The evidence supports the proposal that PEMT2 may have a role in the regulation of 'in vivo' hepatoma and hepatocyte cell division as well as hepatocyte cell death by apoptosis. (+info)Ascites is an abnormal accumulation of fluid in the peritoneal cavity, which is the space between the lining of the abdominal wall and the organs within it. This buildup of fluid can cause the belly to swell and become distended. Ascites can be caused by various medical conditions, including liver cirrhosis, cancer, heart failure, and kidney disease. The accumulation of fluid in the peritoneal cavity can lead to complications such as infection, reduced mobility, and difficulty breathing. Treatment for ascites depends on the underlying cause and may include diuretics, paracentesis (a procedure to remove excess fluid from the abdomen), or treatment of the underlying medical condition.
Chylous ascites is a medical condition characterized by the accumulation of milky, fat-containing fluid in the peritoneal cavity, which is the space within the abdomen that contains the intestines, liver, and other organs. The fluid, called chyle, is normally found in the lymphatic system and is formed when dietary fats are absorbed from the small intestine.
Chylous ascites can occur as a result of damage to the lymphatic vessels that transport chyle from the intestines to the bloodstream. This damage can be caused by various conditions, such as trauma, surgery, tumors, inflammation, or congenital abnormalities. When the lymphatic vessels are damaged, chyle leaks into the peritoneal cavity and accumulates there, leading to ascites.
Symptoms of chylous ascites may include abdominal distension, pain, nausea, vomiting, and weight loss. The condition can be diagnosed through various tests, such as imaging studies or analysis of the fluid in the peritoneal cavity. Treatment typically involves addressing the underlying cause of the condition, as well as managing symptoms and preventing complications. This may include dietary modifications, medications to reduce lymphatic flow, or surgical interventions to repair damaged lymphatic vessels.
I'm sorry for any confusion, but "Carcinoma, Ehrlich Tumor" is not a recognized medical term or a valid medical definition. The term "Ehrlich tumor" is sometimes used to refer to a type of transplantable tumor that was first developed by the German physician Paul Ehrlich in the early 20th century for cancer research purposes. However, it's important to note that this type of tumor is not a naturally occurring cancer and is typically used only in laboratory experiments.
Carcinoma, on the other hand, is a medical term that refers to a type of cancer that starts in cells that line the inner or outer surfaces of organs. Carcinomas can develop in various parts of the body, including the lungs, breasts, colon, and skin.
If you have any specific questions about cancer or a particular medical condition, I would be happy to try to help answer them for you.
A Peritoneovenous Shunt is a medical device used to treat severe ascites, a condition characterized by the accumulation of excess fluid in the abdominal cavity. The shunt consists of a small tube or catheter that is surgically implanted into the abdominal cavity and connected to another tube that is inserted into a vein, usually in the chest or neck.
The shunt works by allowing the excess fluid in the abdomen to flow through the tube and into the bloodstream, where it can be eliminated from the body through the kidneys. This helps to alleviate the symptoms of ascites, such as abdominal pain and swelling, and can improve the patient's quality of life.
Peritoneovenous shunts are typically used in patients who have not responded to other treatments for ascites, such as diuretics or paracentesis (a procedure in which excess fluid is drained from the abdomen using a needle and syringe). While peritoneovenous shunts can be effective in managing ascites, they do carry some risks, including infection, bleeding, and blockage of the shunt. As with any surgical procedure, it's important for patients to discuss the potential benefits and risks with their healthcare provider before deciding whether a peritoneovenous shunt is right for them.
Ascitic fluid is defined as the abnormal accumulation of fluid in the peritoneal cavity, which is the space between the two layers of the peritoneum, a serous membrane that lines the abdominal cavity and covers the abdominal organs. This buildup of fluid, also known as ascites, can be caused by various medical conditions such as liver cirrhosis, cancer, heart failure, or infection. The fluid itself is typically straw-colored and clear, but it may also contain cells, proteins, and other substances depending on the underlying cause. Analysis of ascitic fluid can help doctors diagnose and manage the underlying condition causing the accumulation of fluid.
Tuberculous peritonitis is a specific type of peritonitis (inflammation of the peritoneum, the serous membrane that lines the abdominal cavity and covers the abdominal organs) that is caused by the Mycobacterium tuberculosis bacterium. This form of peritonitis is less common than peritonitis caused by other types of bacteria, but it can occur in people with weakened immune systems or those who have been in close contact with individuals with active TB.
The symptoms of tuberculous peritonitis may include abdominal pain and distension, fever, weight loss, decreased appetite, and ascites (accumulation of fluid in the abdominal cavity). Diagnosis typically involves a combination of clinical evaluation, imaging studies, and laboratory tests, such as cultures or nucleic acid amplification tests (NAATs) to detect the presence of M. tuberculosis in the peritoneal fluid or tissue. Treatment usually involves a prolonged course of multiple antibiotics that are active against M. tuberculosis, along with supportive care to manage any complications or symptoms.
Peritoneal neoplasms refer to tumors or cancerous growths that develop in the peritoneum, which is the thin, transparent membrane that lines the inner wall of the abdomen and covers the organs within it. These neoplasms can be benign (non-cancerous) or malignant (cancerous). Malignant peritoneal neoplasms are often associated with advanced stages of gastrointestinal, ovarian, or uterine cancers and can spread (metastasize) to other parts of the abdomen.
Peritoneal neoplasms can cause various symptoms such as abdominal pain, bloating, nausea, vomiting, loss of appetite, and weight loss. Diagnosis typically involves imaging tests like CT scans or MRIs, followed by a biopsy to confirm the presence of cancerous cells. Treatment options may include surgery, chemotherapy, radiation therapy, or a combination of these approaches, depending on the type, stage, and location of the neoplasm.
Liver cirrhosis is a chronic, progressive disease characterized by the replacement of normal liver tissue with scarred (fibrotic) tissue, leading to loss of function. The scarring is caused by long-term damage from various sources such as hepatitis, alcohol abuse, nonalcoholic fatty liver disease, and other causes. As the disease advances, it can lead to complications like portal hypertension, fluid accumulation in the abdomen (ascites), impaired brain function (hepatic encephalopathy), and increased risk of liver cancer. It is generally irreversible, but early detection and treatment of underlying causes may help slow down its progression.
Ovarian neoplasms refer to abnormal growths or tumors in the ovary, which can be benign (non-cancerous) or malignant (cancerous). These growths can originate from various cell types within the ovary, including epithelial cells, germ cells, and stromal cells. Ovarian neoplasms are often classified based on their cell type of origin, histological features, and potential for invasive or metastatic behavior.
Epithelial ovarian neoplasms are the most common type and can be further categorized into several subtypes, such as serous, mucinous, endometrioid, clear cell, and Brenner tumors. Some of these epithelial tumors have a higher risk of becoming malignant and spreading to other parts of the body.
Germ cell ovarian neoplasms arise from the cells that give rise to eggs (oocytes) and can include teratomas, dysgerminomas, yolk sac tumors, and embryonal carcinomas. Stromal ovarian neoplasms develop from the connective tissue cells supporting the ovary and can include granulosa cell tumors, thecomas, and fibromas.
It is essential to diagnose and treat ovarian neoplasms promptly, as some malignant forms can be aggressive and potentially life-threatening if not managed appropriately. Regular gynecological exams, imaging studies, and tumor marker tests are often used for early detection and monitoring of ovarian neoplasms. Treatment options may include surgery, chemotherapy, or radiation therapy, depending on the type, stage, and patient's overall health condition.
I'm sorry for the confusion, but "Sarcoma, Yoshida" is not a recognized medical term or a specific type of sarcoma in any major oncology reference or database. It appears that "Yoshida" might be referring to a person who described or studied a particular type of sarcoma. However, I cannot find any relevant information related to this exact term.
Sarcomas are cancers that develop from connective tissues such as bones, muscles, tendons, cartilages, nerves, and blood vessels. They can be categorized into two main groups: bone sarcomas and soft tissue sarcomas. There are many subtypes of sarcoma, each with its unique features, diagnostic criteria, and treatment approaches.
If you have more context or information about "Sarcoma, Yoshida," I would be happy to help you further research the topic. However, based on the available data, it is not possible to provide a medical definition for this term.
Experimental liver neoplasms refer to abnormal growths or tumors in the liver that are intentionally created or manipulated in a laboratory setting for the purpose of studying their development, progression, and potential treatment options. These experimental models can be established using various methods such as chemical induction, genetic modification, or transplantation of cancerous cells or tissues. The goal of this research is to advance our understanding of liver cancer biology and develop novel therapies for liver neoplasms in humans. It's important to note that these experiments are conducted under strict ethical guidelines and regulations to minimize harm and ensure the humane treatment of animals involved in such studies.
Portal hypertension is a medical condition characterized by an increased pressure in the portal vein, which is the large blood vessel that carries blood from the intestines, spleen, and pancreas to the liver. Normal portal venous pressure is approximately 5-10 mmHg. Portal hypertension is defined as a portal venous pressure greater than 10 mmHg.
The most common cause of portal hypertension is cirrhosis of the liver, which leads to scarring and narrowing of the small blood vessels in the liver, resulting in increased resistance to blood flow. Other causes include blood clots in the portal vein, inflammation of the liver or bile ducts, and invasive tumors that block the flow of blood through the liver.
Portal hypertension can lead to a number of complications, including the development of abnormal blood vessels (varices) in the esophagus, stomach, and intestines, which are prone to bleeding. Ascites, or the accumulation of fluid in the abdominal cavity, is another common complication of portal hypertension. Other potential complications include encephalopathy, which is a condition characterized by confusion, disorientation, and other neurological symptoms, and an increased risk of bacterial infections.
Treatment of portal hypertension depends on the underlying cause and the severity of the condition. Medications to reduce pressure in the portal vein, such as beta blockers or nitrates, may be used. Endoscopic procedures to band or inject varices can help prevent bleeding. In severe cases, surgery or liver transplantation may be necessary.
Hydrothorax is a medical term that refers to the abnormal accumulation of serous fluid in the pleural space, which is the potential space between the lungs and the chest wall. This condition often results from various underlying pathological processes such as liver cirrhosis, heart failure, or kidney disease, where there is an imbalance in the body's fluid regulation leading to the accumulation of fluid in the pleural cavity. The presence of hydrothorax can cause respiratory distress and other symptoms related to lung function impairment.
Myxedema is not a term used in modern medicine to describe a specific medical condition. However, historically, it was used to refer to the severe form of hypothyroidism, a condition characterized by an underactive thyroid gland that doesn't produce enough thyroid hormones. In hypothyroidism, various body functions slow down, which can lead to symptoms such as fatigue, weight gain, cold intolerance, constipation, and dry skin.
Myxedema specifically refers to the physical signs of severe hypothyroidism, including swelling (edema) and thickening of the skin, particularly around the face, hands, and feet, as well as a puffy appearance of the face. The term myxedema coma was used to describe a rare but life-threatening complication of long-standing, untreated hypothyroidism, characterized by altered mental status, hypothermia, and other systemic manifestations.
Nowadays, healthcare professionals use more precise medical terminology to describe these conditions, such as hypothyroidism or myxedematous edema, rather than the outdated term myxedema.
Hepatorenal syndrome (HRS) is a serious complication that primarily affects people with advanced liver disease, particularly those with cirrhosis. It's characterized by functional renal failure in the absence of structural kidney damage. This means that the kidneys stop working properly, but if they were to be removed and examined, there would be no obvious physical reason for their failure.
The medical definition of hepatorenal syndrome includes specific diagnostic criteria:
1. Presence of liver cirrhosis or fulminant hepatic failure.
2. Evidence of impaired liver function, such as ascites (accumulation of fluid in the abdomen) and elevated levels of bilirubin in the blood.
3. Functional renal failure, defined as a serum creatinine level greater than 1.5 mg/dL or a doubling of the baseline creatinine to a level above 1.5 mg/dL in patients with previously normal renal function.
4. Absence of structural kidney damage, confirmed by a normal urinalysis (no protein or red blood cells in the urine), a high urine sodium concentration (greater than 10 mEq/L), and a low fractional excretion of sodium (less than 1%).
5. No alternative explanation for renal failure, such as sepsis, hypovolemia, or use of nephrotoxic medications.
Hepatorenal syndrome is further divided into two types:
- Type 1 HRS: This form is characterized by a rapid and severe decline in kidney function, with a doubling of the serum creatinine to a level greater than 2.5 mg/dL within two weeks. Type 1 HRS has a poor prognosis, with a median survival time of about two weeks if left untreated.
- Type 2 HRS: This form is characterized by a more gradual and modest decline in kidney function, with a serum creatinine level persistently above 1.5 mg/dL. Type 2 HRS has a better prognosis than type 1, but it still significantly worsens the overall survival of patients with liver cirrhosis.
Hepatorenal syndrome is a serious complication of liver cirrhosis and other forms of advanced liver disease. It requires prompt recognition and treatment to improve outcomes and prevent further deterioration of kidney function.
Experimental neoplasms refer to abnormal growths or tumors that are induced and studied in a controlled laboratory setting, typically in animals or cell cultures. These studies are conducted to understand the fundamental mechanisms of cancer development, progression, and potential treatment strategies. By manipulating various factors such as genetic mutations, environmental exposures, and pharmacological interventions, researchers can gain valuable insights into the complex processes underlying neoplasm formation and identify novel targets for cancer therapy. It is important to note that experimental neoplasms may not always accurately represent human cancers, and further research is needed to translate these findings into clinically relevant applications.
Pleural effusion is a medical condition characterized by the abnormal accumulation of fluid in the pleural space, which is the thin, fluid-filled space that surrounds the lungs and lines the inside of the chest wall. This space typically contains a small amount of fluid to allow for smooth movement of the lungs during breathing. However, when an excessive amount of fluid accumulates, it can cause symptoms such as shortness of breath, coughing, and chest pain.
Pleural effusions can be caused by various underlying medical conditions, including pneumonia, heart failure, cancer, pulmonary embolism, and autoimmune disorders. The fluid that accumulates in the pleural space can be transudative or exudative, depending on the cause of the effusion. Transudative effusions are caused by increased pressure in the blood vessels or decreased protein levels in the blood, while exudative effusions are caused by inflammation, infection, or cancer.
Diagnosis of pleural effusion typically involves a physical examination, chest X-ray, and analysis of the fluid in the pleural space. Treatment depends on the underlying cause of the effusion and may include medications, drainage of the fluid, or surgery.
Peritonitis is a medical condition characterized by inflammation of the peritoneum, which is the serous membrane that lines the inner wall of the abdominal cavity and covers the abdominal organs. The peritoneum has an important role in protecting the abdominal organs and providing a smooth surface for them to move against each other.
Peritonitis can occur as a result of bacterial or fungal infection, chemical irritation, or trauma to the abdomen. The most common cause of peritonitis is a rupture or perforation of an organ in the abdominal cavity, such as the appendix, stomach, or intestines, which allows bacteria from the gut to enter the peritoneal cavity.
Symptoms of peritonitis may include abdominal pain and tenderness, fever, nausea and vomiting, loss of appetite, and decreased bowel movements. In severe cases, peritonitis can lead to sepsis, a life-threatening condition characterized by widespread inflammation throughout the body.
Treatment for peritonitis typically involves antibiotics to treat the infection, as well as surgical intervention to repair any damage to the abdominal organs and remove any infected fluid or tissue from the peritoneal cavity. In some cases, a temporary or permanent drain may be placed in the abdomen to help remove excess fluid and promote healing.
Ascites
Ehrlich ascites carcinoma
Serum-ascites albumin gradient
Budd-Chiari syndrome
Nephrotic syndrome
Paracentesis
Pancreatic fistula
Abdominal ultrasonography
Portal venous pressure
Chukwuedu Nwokolo
Theiler's disease
Remember (2022 film)
List of South Korean films of 2022
Navel
Riddelliine
Transjugular intrahepatic portosystemic shunt
Milroy's disease
Eosinophilic gastroenteritis
Cirrhosis
Fabian Udekwu
Abdominal cavity
Aldo Perroncito
Pacemaker syndrome
Alexey Severtsev
List of dog diseases
Envigo
Puddle sign
Mesothelioma
Uridine phosphorylase
Portopulmonary hypertension
Ascites - Wikipedia
Ascites: Background, Pathophysiology, Etiology
Management of ascites in children
Refractory ascites: midterm results of treatment with a transjugular intrahepatic portosystemic shunt
Differential diagnosis and therapy of ascites
Ascites screening - wikidoc
Ascites | Lima Memorial Health System
Anti-VEGF Antibody, clone VG1 ascites fluid, clone VG1, from mouse | Sigma-Aldrich
Ascites secondary prevention: Revision history - wikidoc
Severe hemorrhage from the epigastric after ascites paracentesis | CREATIS
Ascites, the condition in which a collection of...
Ultrasound for Detection of Ascites and for Guidance of the Paracentesis Procedure: Technique and Review of the Literature
Global Malignant Ascites Treatment Market Report, History and Forecast 2016-2027
Ascites Increases Expression/Function of Multidrug Resistance Proteins in Ovarian Cancer Cells | Masarykova univerzita
Systemic lupus erythematosus presenting with progressive massive ascites and CA-125 elevation indicating Tjalma syndrome? A...
Alcoholic Cirrhosis with Ascites: A Case Report & Treatment Options - Naturopathic Doctor News and Review
Ascites in Small Animals - Digestive System - MSD Veterinary Manual
Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the...
Analysis of the Effect of 5-Fluorouracil on the Synthesis and Translation of Polysomal Poly(A)RNA from Ehrlich Ascites Cells |...
JCI Insight - CRIg-expressing peritoneal macrophages are associated with disease severity in patients with cirrhosis and ascites
143 Creation of guidelines for management of patients undergoing abdominal paracentesis for malignant ascites at john eastwood...
Ascites
Malignant ascites<...
Specimens for Anthrax Diagnosis by Clinical Presentation | CDC
Cirrhosis: Practice Essentials, Overview, Etiology
Cirrhosis: Practice Essentials, Overview, Etiology
Ascites - Medic Journal
ascites - Vetcetera
Ascites - BeatCancer
Paracentesis11
- Most experts recommend diagnostic paracentesis if the ascites is new or if the person with ascites is being admitted to the hospital. (wikipedia.org)
- Success was defined as survival with no further therapeutic paracentesis and decreased ascites. (nih.gov)
- Objective: To review the use of ultrasound (US) for the detection of free intraperitoneal fluid (ascites) and for the procedural guidance of the paracentesis procedure. (scirp.org)
- Wiese, S., Mortensen, C. and Bendtsen, F. (2011) Few Complications after Paracentesis in Patient with Cirrhosis and Refractory Ascites. (scirp.org)
- Background The inpatient unit at John Eastwood Hospice (JEH) is increasingly providing care for patients with malignant ascites, allowing the relief of symptoms via paracentesis. (bmj.com)
- Paracentesis is essential in determining whether ascites is caused by portal hypertension or by another process. (medscape.com)
- Management of Ascites usually involves a combination of prescription medications such as diuretics, sodium restriction, and occasionally, therapeutic paracentesis. (beatcancer.eu)
- Sometimes, a large volume paracentesis may be necessary if the ascites is difficult to manage. (hopkinsmedicine.org)
- Patients with newonset ascites should receive diagnostic paracentesis consisting of cell count, total protein test, albumin level, and bacterial culture and sensitivity. (web.app)
- METHODS AND RESULTS: Prospective analysis of patients with ascites who were referred for paracentesis. (unibas.ch)
- Paracentesis of ascites normalized precordial leads low-voltage, while limbs leads low voltage remained. (unibas.ch)
Fluid43
- Ascites is the abnormal build-up of fluid in the abdomen. (wikipedia.org)
- Ascites describes the condition of pathologic fluid collection within the abdominal cavity (see the image below). (medscape.com)
- This computed tomography scan demonstrates free intraperitoneal fluid due to urinary ascites. (medscape.com)
- Hypoalbuminemia and reduced plasma oncotic pressure favor the extravasation of fluid from the plasma to the peritoneal fluid, and, thus, ascites is infrequent in patients with cirrhosis unless both portal hypertension and hypoalbuminemia are present. (medscape.com)
- Ascites is a build-up of fluid in the lining of the tummy (abdomen). (macmillan.org.uk)
- Ascites is often managed by draining the fluid. (macmillan.org.uk)
- Removing the excess fluid from the tummy is a common and effective treatment for ascites. (macmillan.org.uk)
- Ascites is the pathologic accumulation of fluid within the peritoneal cavity. (nih.gov)
- Ascites is the build-up of fluid in the space between the lining of the abdomen and abdominal organs. (limamemorial.org)
- Your doctor may also use a thin needle to withdraw ascites fluid from your belly. (limamemorial.org)
- The fluid is tested to look for the cause of ascites and to check if the fluid is infected. (limamemorial.org)
- Unpurified mouse monoclonal IgG1κ in ascites fluid containing no preservatives. (sigmaaldrich.com)
- First, US techniques used for the identification of ascites and in the quantification of fluid pockets amenable to aspiration will be discussed. (scirp.org)
- Ascites, the condition in which a collection of fluid is formed in the peritoneal cavity. (sacklunch.net)
- Ascites is the abdominal accumulation of fluid. (msdvetmanual.com)
- In conclusion, ascites fluid macrophage subset distribution and phagocytic capacity is highly variable among patients with chronic liver disease. (jci.org)
- A and B ) Murine peritoneal macrophage-specific gene set enrichment with respect to the ascites fluid macrophage profile. (jci.org)
- Ascites is a condition that occurs when fluid collects in spaces in your belly (abdomen). (tidelandshealth.org)
- Ascites refers to an abnormal accumulation of fluid in the abdominal cavity, often resulting from severe liver disease, like cirrhosis. (beatcancer.eu)
- Ascites, a medical condition characterized by the unusual accumulation of fluid within the peritoneal cavity, often pertains to severe liver issues, such as cirrhosis. (beatcancer.eu)
- From the medical perspective, Ascites is defined as the abnormal accumulation of fluid in the abdominopelvic cavity, more specifically, within the peritoneal space. (beatcancer.eu)
- Ascites materializes due to a complex physiological process involving increased pressure in the liver's blood vessels and reduced albumin levels, which help retain fluid within the blood vessels. (beatcancer.eu)
- Furthermore, the liver, along with the kidneys and heart, significantly influences Ascites development due to their roles in fluid balance and blood vessel pressure. (beatcancer.eu)
- Lab tests, including liver function tests, kidney function tests, and ascitic fluid analysis, are also critical in diagnosing Ascites. (beatcancer.eu)
- symptomatic measures for ascites include the appointment of diuretics, puncture removal of fluid from the abdominal cavity. (medic-journal.com)
- The accumulation of peritoneal fluid in ascites is accompanied by an increase in intra-abdominal pressure, pushing the dome of the diaphragm into the thoracic cavity. (medic-journal.com)
- Ascites is defined as a pathologic accumulation of intraperitoneal fluid. (unboundmedicine.com)
- Ascites is excess fluid in your abdominal cavity. (hopkinsmedicine.org)
- A relatively simple bedside procedure in which one inserts a needle into the abdomen, thereby evacuating either a small amount of ascites fluid for diagnostic purposes, or large amounts of fluid for therapeutic purposes. (web.app)
- Ascites1, but for the confirmation of ascites, it is required that at least 1500 ml of fluid should be present in peritoneal cavity and also detectable by clinical examination but significantly more in obese person ascites2 muhammed et al. (web.app)
- Ascites is a term that refers to the accumulation of fluid in the abdomen , which may arise from various causes. (thehealthboard.com)
- Typically, cancer patients suffer weight loss, but if they also develop malignant ascites, they may gain weight due to the large amount of fluid in the abdomen. (thehealthboard.com)
- Excess fluid containing cancer cells builds-up when a person has malignant ascites. (thehealthboard.com)
- Ascites is generally a medical condition where in the peritoneal cavity of the abdomen is filled with fluid. (searchherbalremedy.com)
- Xa ulapho, yenza uvavanyo lomzimba kwaye ususe i-ascites fluid yokuvavanya . (notigatos.es)
- Sekunjalo, kufuneka siyazi loo nto into ahlala eyenza kukukhupha i-ascites fluid qho kwiiyure okanye iintsuku ezimbalwa, kwaye umnike ukutya okunetyuwa encinci . (notigatos.es)
- Ascites is the accumulation of protein-containing (ascitic) fluid within the abdomen. (msdmanuals.com)
- Collection of fluid in abdominal cavity is called as ascites. (gastroliver.in)
- PleurX Catheter (Peritoneal Catheter System) drains fluid accumulation, from the chest (pleural fluid) or abdominal cavity (ascites). (ucrad.com)
- Symptoms of excess abdominal fluid (ascites) include abdominal swelling and pain. (ucrad.com)
- The PleurX System drains the pleural fluid or ascites right at home. (ucrad.com)
- In simple words, ascites is a bodily disorder caused due to the build-up of fluid in the abdominal cavity. (stylecraze.com)
- A report published in StatPearls found that people with cirrhotic ascites (fluid buildup in the abdomen due to liver cirrhosis) have a 50% mortality rate in 3 years. (stylecraze.com)
Chylous6
- Successful management of chylous ascites with total parenteral. (web.app)
- CHYLOUS Ascites is an unusual complication of pancreatoduodenectomy. (jamanetwork.com)
- Chylous Ascites is a sequela of an internal lymph fistula, usually of obstructive origin, secondary to either neoplasm or trauma in the majority. (jamanetwork.com)
- Chylous ascites - This is an uncommon type of ascites. (stylecraze.com)
- 1 A fourth group of miscellaneous causes includes cases of chylous ascites, liver "giant cell" transformation, and others. (jamanetwork.com)
- Obstruction of lymphatics may result in lymphangioleiomyomas, chylothorax, and chylous ascites. (medscape.com)
Abdomen4
- People with certain cancers in the abdomen may develop ascites. (limamemorial.org)
- Ascites can set the stage for an infection in your abdomen. (tidelandshealth.org)
- Conversely, patients with Ascites often manifest symptoms like abdominal distension, rapid weight gain, reduced appetite, and discomfort or pain in the abdomen. (beatcancer.eu)
- Ascites is a disorder where the abdomen builds up fluids and leads to bloating, breathlessness and chest pain. (searchherbalremedy.com)
Develop ascites4
- Of those with cirrhosis, more than half develop ascites in the ten years following diagnosis. (wikipedia.org)
- Of those in this group who develop ascites, half will die within three years. (wikipedia.org)
- Within 10 years of the diagnosis of cirrhosis, more than 50% of patients develop ascites. (ndnr.com)
- Patients with chronic liver disease often develop ascites, though it may be caused by other factors. (hopkinsmedicine.org)
Refractory ascites8
- To assess midterm results and examine factors associated with successful treatment of refractory ascites with creation of a transjugular intrahepatic portosystemic shunt (TIPS). (nih.gov)
- In 50 patients with refractory ascites, TIPS creation was performed. (nih.gov)
- Scholars@Duke publication: Transjugular intrahepatic portosystemic shunt (TIPS) in patients with refractory ascites: effect on body weight and Child-Pugh score. (duke.edu)
- OBJECTIVE: This study suggests that patients with medically refractory ascites treated with transjugular intrahepatic portosystemic shunt (TIPS) may have improved in overall clinical status. (duke.edu)
- METHODS: We performed a retrospective study of 35 patients with medically refractory ascites treated with TIPS. (duke.edu)
- CONCLUSION: This study suggests that patients treated with medically refractory ascites with TIPS may have improvement in overall clinical status, as measured by increase in lean body mass and improvement in Child-Pugh score. (duke.edu)
- Refractory ascites - These are ascites that recur after treatment. (stylecraze.com)
- It was further estimated that people with refractory ascites (ascites after treatment) had a survival rate of less than 50% in 1 year. (stylecraze.com)
Portal hypertension8
- 1.1 g/dL) indicates the ascites is due to portal hypertension. (wikipedia.org)
- Although many pathogenic processes have been implicated in the development of abdominal ascites, about 75% likely occur as a result of portal hypertension in the setting of liver cirrhosis, with the remainder due to infective, inflammatory, and infiltrative conditions. (medscape.com)
- Ascites results from high pressure in certain veins of the liver (portal hypertension) and low blood levels of a protein called albumin . (limamemorial.org)
- Frequent causes of ascites are diseases occurring with portal hypertension - an increase in pressure in the portal system of the liver (portal vein and its tributaries). (medic-journal.com)
- In adults, ascites is most often due to portal hypertension from cirrhosis. (unboundmedicine.com)
- Ascites in hepatic cirrhosis is associated with advanced liver disease and with poor hepatic function and portal hypertension, and consequently it is also associated with a poor prognosis. (web.app)
- The formation of ascites in the cirrhotic patient is caused by a complex chain of pathophysiological events involving portal hypertension and progressive vascular dysfunction. (web.app)
- In patients with advanced liver disease, portal hypertension is essential for the formation of ascites. (web.app)
Management of ascites3
- The medical and surgical management of ascites in children is dependent on targeting the underlying etiology. (nih.gov)
- Use of US for both the diagnostic and therapeutic management of ascites should be advocated as an essential skill for physicians and other health care providers caring for these patients. (scirp.org)
- World Gastroenterology Organization (2014) WGO Practice Guideline: Condition: Management of Ascites Complicating Cirrhosis in Adults. (scirp.org)
Symptoms7
- Find out about symptoms and how to treat ascites. (macmillan.org.uk)
- Symptoms may develop slowly or suddenly depending on the cause of ascites. (limamemorial.org)
- What are the symptoms of ascites? (tidelandshealth.org)
- For patients with end-stage liver disease who present with ascites and varices, the doctor may not need to perform any diagnostic tests and can confirm a diagnosis based on symptoms. (hopkinsmedicine.org)
- Malignant ascites symptoms may include swelling of the hands. (thehealthboard.com)
- Malignant ascites symptoms may include loss of appetite. (thehealthboard.com)
- The main aim of malignant ascites treatment is frequently to lessen the depressing and agonizing symptoms experienced by most patients. (thehealthboard.com)
Cause ascites4
- This can also cause ascites. (fattyliverdisease.com)
- Other non-liver related factors can cause ascites including. (fattyliverdisease.com)
- This overload of water can result in leakage and cause ascites to form. (fattyliverdisease.com)
- The risk of this problem is higher in people who have any of the health problems that cause ascites. (epnet.com)
Serum-ascites3
- The serum-ascites albumin gradient (SAAG) is probably a better discriminant than older measures (transudate versus exudate) for the causes of ascites. (wikipedia.org)
- A doctor orders different tests like serum ascites albumin gradient. (fattyliverdisease.com)
- What does Serum Ascites Albumin Gradient Test? (fattyliverdisease.com)
Massive ascites3
- Systemic lupus erythematosus presenting with progressive massive ascites and CA-125 elevation indicating Tjalma syndrome? (wjgnet.com)
- Massive ascites can be accompanied by significant loss of protein and electrolyte disturbances. (medic-journal.com)
- Extracardiac manifestations, such as massive ascites and liver cirrhosis. (web.app)
Etiology1
- Ascites of tuberculous etiology are also characterized by weight loss, fever, and general intoxication phenomena. (medic-journal.com)
Common cause of ascites2
- The most common cause of ascites is cirrhosis of the liver. (tidelandshealth.org)
- This is another common cause of ascites. (fattyliverdisease.com)
Hepatic encephalopathy2
- The development of complications, such as ascites, variceal bleeding, hepatic encephalopathy, spontaneous bacterial peritonitis, or hepatorenal syndrome, has a significant impact on the prognosis of patients with alcoholic cirrhosis. (ndnr.com)
- Liver cirrhosis is the endstage of different chronic liver diseases, and is often neglected until complications, such as variceal haemorrhage, spontaneous bacterial peritonitis, ascites, or hepatic encephalopathy occur. (web.app)
Malignant Ascites Treatment4
- The research report studies the Malignant Ascites Treatment market using different methodologies and analyses to provide accurate and in-depth information about the market. (marketresearch.com)
- The global Malignant Ascites Treatment market size is projected to reach US$ 642.07 million by 2027, from US$ 439.75 million in 2020, at a CAGR of 4.79% during 2021-2027. (marketresearch.com)
- The global Malignant Ascites Treatment market is segmented by company, region (country), by Type, and by Application. (marketresearch.com)
- Players, stakeholders, and other participants in the global Malignant Ascites Treatment market will be able to gain the upper hand as they use the report as a powerful resource. (marketresearch.com)
Peritonitis5
- Ascites and spontaneous bacterial peritonitis. (limamemorial.org)
- Ascites in tuberculous peritonitis is caused by secondary infection of the peritoneum due to genital tuberculosis or intestinal tuberculosis. (medic-journal.com)
- Izifo eziphambili kunye neemeko ezinokubangela ukuba iikati zibe ne-ascites zezi: ukwenzakala komzimba, ukusilela kwentliziyo, ukungaphumeleli kwilungu lesisu, umhlaza, okanye i-feline esosulelayo i-peritonitis. (notigatos.es)
- I-Feline peritonitis echaphazelayo Esinye isizathu se-ascites kwiikati, i-feline peritonitis esosulelayo, okanye i-FIP, ibangelwa yintsholongwane ekhula kwiiseli ezimhlophe zegazi, ichaphazela ngqo ulusu lwangaphakathi lweekati. (notigatos.es)
- Patients with liver diseases can have infection of ascites, known as Spontaneous Bacterial Peritonitis (SBP). (gastroliver.in)
Lead to ascites2
- Diseases that can cause severe liver damage can lead to ascites. (limamemorial.org)
- Apart from this, cancers that affect different organs like the colon, stomach, liver, breast , and pancreas are another major cause that can lead to ascites. (stylecraze.com)
Cirrhosis and Ascites2
Development of ascites2
- Protein deficiency, kidney diseases (nephrotic syndrome, chronic glomerulonephritis), heart failure, myxedema, gastrointestinal diseases (pancreatitis, Crohn's disease, chronic diarrhea), lymphostasis associated with compression of the thoracic lymphatic duct, lymphangiectasis and difficulty in lymph outflow from the abdominal cavity predispose to the development of ascites. (medic-journal.com)
- The development of ascites is an important landmark in the natural history of cirrhosis and has been proposed as an indication for liver transplantation. (web.app)
Complications of ascites1
- What are possible complications of ascites? (tidelandshealth.org)
Patients23
- Hepatic artery nitric oxide synthase activity is greater in patients with ascites than in those without ascites. (medscape.com)
- In 23 (62%) of 37 patients not lost to follow-up, ascites was controlled successfully at 1-3 months. (nih.gov)
- In all 14 patients alive at 1-year follow-up, ascites was controlled successfully. (nih.gov)
- Runyon, B.A. (1998) Management of Adult Patients with Ascites Caused by Cirrhosis. (scirp.org)
- As a common symptom in stage III/IV ovarian cancer patients, ascites is associated with cancer progression. (muni.cz)
- Here, we demonstrate that when cultured with ascites derived from ovarian cancer-bearing mice, a murine ovarian cancer cell line became less sensitive to paclitaxel, a first line chemotherapeutic agent for ovarian cancer patients. (muni.cz)
- To demonstrate relevance of our findings to ovarian cancer patients, we studied relative efflux in human ovarian cancer cells obtained from either patient ascites or from primary tumor. (muni.cz)
- 1 The median survival of patients with ascites refractory to medical treatment is approximately 6 months. (ndnr.com)
- The quality of life for patients with Ascites may be compromised, underscoring the importance of psychological support, lifestyle adjustments, and effective coping mechanisms. (beatcancer.eu)
- Ascites completely resolved or improved in 23 of 24 patients (96%) who had long term follow-up. (duke.edu)
- Ascites is a common problem and patients present to a broad range of medical specialties. (web.app)
- About the 60 % of patients with compensated cirrhosis develops ascites during the first 10 years after diagnosis. (web.app)
- When ascites develops in patients diagnosed with cancer, it is often referred to as malignant ascites. (thehealthboard.com)
- AIMS: Electrocardiographic (ECG) changes in patients with ascites are not well studied. (unibas.ch)
- The aim of this study was to evaluate ECG changes in patients with ascites. (unibas.ch)
- In six patients the same ECG protocol was performed after removal of ascites. (unibas.ch)
- Ten hospitalized patients without ascites served as controls. (unibas.ch)
- Twenty patients with ascites were analysed. (unibas.ch)
- Cranial placement of the precordial electrodes increased SigmaQRS in all patients with ascites. (unibas.ch)
- Cranial placement of the precordial electrodes in patients without ascites decreases SigmaV1-V6. (unibas.ch)
- CONCLUSION: We describe a phenomenon of precordial voltage changes in patients with ascites, not reported in the literature yet. (unibas.ch)
- Patients with chronic liver disease who have ascites are patients with advanced diseases. (gastroliver.in)
- Available at: http://patients.gi.org/topics/ascites. (epnet.com)
Liver cirrhosis2
- Liver cirrhosis is responsible for 85% of ascites. (stylecraze.com)
- Abdominal examination was are local formation of immune complexes done to detect cases of enlarged liver or induced by viral antigens, or a local tissue spleen and presence of ascites as complica- inflammation induced by autoantibodies tions of liver cirrhosis. (who.int)
Cirrhotic ascites2
Diagnosis3
- Establishing Ascites diagnosis entails a careful medical history review and physical examination initially, followed by diagnostic procedures like ultrasound or CT scans. (beatcancer.eu)
- Approach to the patient with ascites differential diagnosis. (web.app)
- Pathophysiology, diagnosis and treatment of ascites in cirrhosis 73 tention in cirrhosis. (web.app)
Pathophysiology1
- This article considers the aetiology and pathophysiology of malignant ascites and explores the best form of management. (dundee.ac.uk)
SAAG1
- The SAAG test can help figure out what's causing the ascites. (fattyliverdisease.com)
Abdominal distension1
- Mild ascites is hard to notice, but severe ascites leads to abdominal distension. (wikipedia.org)
Peritoneal carcinomatosis1
- Those with ascites due to cancer (peritoneal carcinomatosis) may complain of chronic fatigue or weight loss. (wikipedia.org)
Ultrasound1
- Ascites may be diagnosed by ultrasound, CT, or MRI. (ucrad.com)
Susceptibility2
- Immortalized cell lines developed from human ascites show increased susceptibility to efflux inhibitors (MRP1, BCRP) compared to a cell line derived from a primary ovarian cancer, suggesting an association between ascites and efflux function in human ovarian cancer. (muni.cz)
- The impact of Ascites on the body is profound, as it can cause severe abdominal discomfort, breathing difficulties, and susceptibility to infections. (beatcancer.eu)
Pancreatic1
- Individuals suffering from uterine cancer, colon cancer, ovarian cancer, and pancreatic cancer have a higher risk of developing malignant ascites. (thehealthboard.com)
Ovarian cancer5
- However, whether ascites drives multidrug resistance in ovarian cancer cells awaits elucidation. (muni.cz)
- Moreover, incubation of murine ovarian cancer cells in vitro with ascites drives efflux function in these cells. (muni.cz)
- Efflux in ascites-derived human ovarian cancer cells is associated with increased expression of ABC transporters compared to that in primary tumor-derived human ovarian cancer cells. (muni.cz)
- Collectively, our findings identify a novel activity for ascites in promoting ovarian cancer multidrug resistance. (muni.cz)
- When my sister got ovarian cancer, she soon developed malignant ascites. (thehealthboard.com)
Wikidoc1
- 16:01 16:01, 23 August 2012 ‎ Raviteja Reddy Guddeti talk contribs ‎ 261 bytes +261 ‎ Created page with '__NOTOC__ {{Ascites}} Please help WikiDoc by adding more content here. (wikidoc.org)
Treatment5
- TIPS creation is often useful in treatment of severe ascites not controlled with medical therapy. (nih.gov)
- Investigation and treatment of malignant ascites are often in the hands of the general surgeon and can be difficult. (dundee.ac.uk)
- The prognosis of Ascites is variable, greatly dictated by the underlying condition and patient's adherence to treatment. (beatcancer.eu)
- Capturing the complexity of Ascites, this article underscores the critical nature of early detection, effective treatment, and regular medical follow-up. (beatcancer.eu)
- The treatment gets used most often when ascites keeps happening or is serious. (fattyliverdisease.com)
Hemorrhoids1
- A significant increase in intra-abdominal pressure with ascites can lead to the development of umbilical or femoral hernias, varicocele, hemorrhoids, rectal prolapse. (medic-journal.com)
Manifestations1
- RÉSUMÉ Nous avons passé en revue les manifestations dermatologiques liées à l'infection chronique par le virus de l'hépatite C (VHC) et leur rapport avec l'état hépatique. (who.int)
Fetal1
- The purpose of this report is to describe what we believe to be the first case of fetal ascites, secondary to generalized cytomegalovirus infection proved by culture. (jamanetwork.com)
Differential1
- Ascites macrophage data are ranked according to differential expression between subpopulations (indicated by red-blue bars), and the gene set of interest is mapped onto this profile (black bars) to determine enrichment score (green lines) (Thio. (jci.org)
Heart failure2
- Those with ascites due to heart failure may also complain of shortness of breath as well as wheezing and exercise intolerance. (wikipedia.org)
- Thus, with ascites, respiratory and heart failure, pronounced metabolic disorders can develop, which worsens the prognosis of the underlying disease. (medic-journal.com)
Symptom3
- Ascites can be a symptom of many type of cancer . (macmillan.org.uk)
- The main symptom of ascites is bloating and a swollen tummy. (macmillan.org.uk)
- In fact, what's often referred to as "beer belly" might actually be a symptom of ascites. (fattyliverdisease.com)
Obstruction1
- In the latter case it is due either to disease of the peritoneum (inflammation or morbid growth), or to obstruction to the portal circulation, the most common cause of which is cirrhosis of the liver (q.v.). Ascites may be simulated by several other conditions, from which it has to be distinguished by careful examination. (sacklunch.net)
Occur1
- Ascites tends to occur in long-standing (chronic) rather than in short-lived (acute) liver disorders. (msdmanuals.com)